CSBR - Champions Oncology, Inc. Stock Price and Quote

CSBR [NASD]

Index	-	P/E	-	EPS (ttm)	-0.23	Insider Own	16.80%	Shs Outstand	13.56M	Perf Week	-1.20%
Market Cap	54.08M	Forward P/E	41.00	EPS next Y	0.10	Insider Trans	0.56%	Shs Float	10.19M	Perf Month	-11.83%
Income	-3.10M	PEG	-	EPS next Q	-0.12	Inst Own	72.20%	Short Float / Ratio	0.56% / 4.61	Perf Quarter	-10.09%
Sales	53.70M	P/S	1.01	EPS this Y	55.80%	Inst Trans	-0.69%	Short Interest	0.06M	Perf Half Y	-48.10%
Book/sh	0.52	P/B	7.88	EPS next Y	350.00%	ROA	-8.80%	Target Price	9.50	Perf Year	-51.65%
Cash/sh	0.88	P/C	4.66	EPS next 5Y	15.00%	ROE	-36.30%	52W Range	3.75 - 9.88	Perf YTD	-9.09%
Dividend	-	P/FCF	18.65	EPS past 5Y	15.60%	ROI	6.30%	52W High	-58.50%	Beta	0.91
Dividend %	-	Quick Ratio	1.00	Sales past 5Y	26.10%	Gross Margin	47.10%	52W Low	9.33%	ATR	0.14
Employees	230	Current Ratio	1.00	Sales Q/Q	-3.00%	Oper. Margin	-5.60%	RSI (14)	42.31	Volatility	2.59% 2.86%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-428.90%	Profit Margin	-5.80%	Rel Volume	0.76	Prev Close	4.18
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	0.00%	Avg Volume	12.48K	Price	4.10
Recom	2.00	SMA20	-4.77%	SMA50	-4.00%	SMA200	-37.28%	Volume	9,481	Change	-1.91%

Nov-18-19

Initiated

The Benchmark Company

Speculative Buy

Mar-15-23 03:50PM	Champions Oncology Reports Quarterly Revenue of $12.8 Million ACCESSWIRE
Mar-13-23 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023 ACCESSWIRE
Dec-16-22 08:48AM	Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2023 Earnings Call Transcript Insider Monkey -10.91%
Dec-13-22 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $14.3 Million ACCESSWIRE +5.21%
Dec-09-22 04:30PM	Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022 ACCESSWIRE
04:00PM	Loading…
Sep-08-22 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $13.7 Million ACCESSWIRE
Sep-06-22 04:00PM	Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022 ACCESSWIRE -5.38%
Aug-15-22 08:08AM	What Type Of Shareholders Make Up Champions Oncology, Inc.'s (NASDAQ:CSBR) Share Registry? Simply Wall St.
Jul-23-22 09:57AM	We Ran A Stock Scan For Earnings Growth And Champions Oncology (NASDAQ:CSBR) Passed With Ease Simply Wall St.
Jul-21-22 04:00PM	Champions Oncology Reports Quarterly Revenue of $12.9 Million ACCESSWIRE
Jul-14-22 04:00PM	Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022 ACCESSWIRE
Jun-13-22 06:30AM	Investors in Champions Oncology (NASDAQ:CSBR) have made a impressive return of 197% over the past five years Simply Wall St.
May-31-22 08:30AM	Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics ACCESSWIRE
May-03-22 08:30AM	Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo ACCESSWIRE
May-02-22 01:16PM	Champions Oncology, Inc.'s (NASDAQ:CSBR) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? Simply Wall St.
04:45PM	Loading…
Mar-15-22 04:45PM	Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million ACCESSWIRE
Mar-11-22 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022 ACCESSWIRE
Mar-07-22 01:10PM	Do Institutions Own Champions Oncology, Inc. (NASDAQ:CSBR) Shares? Simply Wall St.
Feb-15-22 08:30AM	Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors ACCESSWIRE +6.47%
Jan-20-22 08:30AM	Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates ACCESSWIRE
Jan-04-22 08:30AM	Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs ACCESSWIRE
05:07AM	Champions Oncology's (NASDAQ:CSBR) investors will be pleased with their impressive 149% return over the last five years Simply Wall St.
Dec-13-21 04:20PM	Champions Oncology Reports Record Quarterly Revenue of $11.8 Million ACCESSWIRE
Dec-06-21 09:20AM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021 ACCESSWIRE
Nov-05-21 08:24AM	Champions Oncology, Inc.'s (NASDAQ:CSBR) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? Simply Wall St.
Oct-20-21 10:25AM	Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus ACCESSWIRE
Sep-13-21 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $11.3 Million ACCESSWIRE
Sep-06-21 03:00PM	Champions Oncology, Inc. (CSBR) Reports Next Week: What You Should Expect Zacks
07:09AM	What Kind Of Shareholders Hold The Majority In Champions Oncology, Inc.'s (NASDAQ:CSBR) Shares? Simply Wall St.
Sep-02-21 04:30PM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021 ACCESSWIRE
08:30AM	Loading…
Jul-26-21 08:30AM	Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development ACCESSWIRE
Jul-22-21 08:00AM	Champions Oncology Reports Quarterly Revenue of $10.6 Million ACCESSWIRE
Jul-14-21 08:30AM	Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021 ACCESSWIRE
Jul-08-21 03:06AM	The Champions Oncology (NASDAQ:CSBR) Share Price Is Up 335% And Shareholders Are Delighted Simply Wall St.
Jun-15-21 09:00AM	Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabolomics, and Multi-Omic Data Analysis Solutions ACCESSWIRE
Apr-29-21 03:31AM	Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation Simply Wall St. +5.34%
Apr-16-21 12:00PM	Champions Oncology, Inc. (CSBR) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Mar-16-21 10:52AM	Strength Seen in Champions Oncology, Inc. (CSBR): Can Its 15.3% Jump Turn into More Strength? Zacks
Mar-15-21 02:13AM	What Type Of Shareholders Own The Most Number of Champions Oncology, Inc. (NASDAQ:CSBR) Shares? Simply Wall St. +15.31%
Mar-11-21 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $10.8 Million ACCESSWIRE
02:30PM	Champions Oncology, Inc. to Host Earnings Call ACCESSWIRE
Mar-05-21 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021 ACCESSWIRE
Mar-04-21 12:30PM	Analysts Estimate Champions Oncology, Inc. (CSBR) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-22-21 09:00AM	Champions Oncology Announces Addition to Board of Directors ACCESSWIRE
Jan-29-21 12:24AM	Can You Imagine How Jubilant Champions Oncology's (NASDAQ:CSBR) Shareholders Feel About Its 220% Share Price Gain? Simply Wall St.
Jan-19-21 09:00AM	Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics ACCESSWIRE
Jan-05-21 08:30AM	Champions Oncology Announces the Expansion of Lumin Bioinformatics: Now Featuring a Highly Valuable Set of Proteomic Data and Analytics ACCESSWIRE
Dec-15-20 12:22AM	Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 25%? Simply Wall St.
Dec-14-20 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $10.1 Million ACCESSWIRE
Dec-07-20 04:00PM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2020 ACCESSWIRE
Nov-16-20 04:40PM	Champions Oncology Announces the Launch of Lumin Bioinformatics, Its New Oncology Data-Driven SaaS Program ACCESSWIRE +14.94%
Nov-11-20 09:00AM	Champions Oncology Expands Its Immuno-Oncology Research Offering by Launching a Unique Autologous Tumor Infiltrating Lymphocyte Ex Vivo Platform ACCESSWIRE
Oct-31-20 10:08AM	Should You Investigate Champions Oncology, Inc. (NASDAQ:CSBR) At US$8.78? Simply Wall St.
Sep-16-20 07:27AM	Champions Oncology, Inc. Just Beat Revenue Estimates By 11% Simply Wall St.
Sep-14-20 04:00PM	Champions Oncology Reports Record Quarterly Revenue of $9.5 Million ACCESSWIRE
Sep-08-20 04:30PM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 14, 2020 ACCESSWIRE -9.35%
Jul-30-20 07:21AM	Champions Oncology, Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts Simply Wall St.
Jul-27-20 04:01PM	Champions Oncology Reports Quarterly Revenue of $8.8 Million ACCESSWIRE
Jul-22-20 08:00AM	Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 27, 2020 ACCESSWIRE +6.75%
Jul-15-20 03:55PM	What Type Of Shareholders Own The Most Number of Champions Oncology, Inc. (NASDAQ:CSBR) Shares? Simply Wall St.
Jun-17-20 09:37AM	The Truth About Market Timing - June 17, 2020 Zacks
May-27-20 07:05AM	If You Had Bought Champions Oncology (NASDAQ:CSBR) Shares Three Years Ago You'd Have Made 278% Simply Wall St.
Apr-28-20 09:50AM	Timing the Market, Is it Possible? - April 28, 2020 Zacks
Apr-27-20 07:20AM	Is Champions Oncology, Inc. (NASDAQ:CSBR) A Volatile Stock? Simply Wall St.
Mar-28-20 09:23AM	Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth Simply Wall St.
Mar-16-20 09:35AM	When Does Market Timing Actually Work? - March 16, 2020 Zacks -14.49%
Mar-12-20 04:17PM	Champions Oncology Reports Record Quarterly Revenue of $9.0 Million ACCESSWIRE -12.71%
Mar-10-20 08:30AM	Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2020 ACCESSWIRE -6.49%
Feb-26-20 09:32AM	Timing the Market, Is it Possible? - February 26, 2020 Zacks
Feb-18-20 05:44AM	Does Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Pay Reflect Performance? Simply Wall St.
Feb-05-20 09:23AM	When Does Market Timing Actually Work? - February 05, 2020 Zacks
Jan-29-20 09:00AM	The Children's Cancer Therapy Development Institute is collaborating with Champions Oncology and The Jackson Laboratory to provide RACE Act/PREA pediatric cancer study plan services ACCESSWIRE
Jan-17-20 09:34AM	How to Time the Markets Like an Investing Pro - January 17, 2020 Zacks
Jan-13-20 06:07AM	Is There An Opportunity With Champions Oncology, Inc.'s (NASDAQ:CSBR) 42% Undervaluation? Simply Wall St.
Dec-24-19 09:37AM	The Market Timing Secrets No One Talks About - December 24, 2019 Zacks
Dec-16-19 04:00PM	Champions Oncology Reports Quarterly Revenue of $7.6 Million ACCESSWIRE +12.08%
Dec-09-19 08:30AM	Champions Oncology to Announce Second Quarter Financial Results on Monday, December 16, 2019 ACCESSWIRE
Dec-08-19 08:59AM	Investors Who Bought Champions Oncology (NASDAQ:CSBR) Shares Three Years Ago Are Now Up 231% Simply Wall St.
Dec-04-19 08:36AM	Simple Market Timing Strategies That Work - December 04, 2019 Zacks +6.54%
Nov-14-19 08:53AM	The Truth About Market Timing - November 14, 2019 Zacks
Nov-13-19 05:00PM	Champions Oncology and PhenoVista Biosciences Announce a Strategic Partnership to provide Oncology Imaging-based Phenotypic Assays for Preclinical Drug Development ACCESSWIRE -5.90%
Nov-12-19 07:27AM	What Kind Of Shareholders Own Champions Oncology, Inc. (NASDAQ:CSBR)? Simply Wall St.
Oct-24-19 09:00AM	The Truth About Market Timing - October 24, 2019 Zacks
Oct-18-19 07:41AM	We Think Champions Oncology (NASDAQ:CSBR) Can Easily Afford To Drive Business Growth Simply Wall St.
Oct-03-19 08:49AM	When Does Market Timing Actually Work? - October 03, 2019 Zacks +5.22%
Sep-25-19 12:43PM	What Does Champions Oncology, Inc.'s (NASDAQ:CSBR) Share Price Indicate? Simply Wall St.
Sep-16-19 04:00PM	Champions Oncology Reports Quarterly Revenue of $6.7 Million ACCESSWIRE +14.05%
02:30PM	Champions Oncology, Inc. to Host Earnings Call ACCESSWIRE
Sep-13-19 08:39AM	The Truth About Market Timing - September 13, 2019 Zacks
Sep-09-19 08:30AM	Champions Oncology to Announce First Quarter Financial Results on Monday, September 16, 2019 ACCESSWIRE
Sep-02-19 01:30PM	How Much is Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Getting Paid? Simply Wall St.
Aug-26-19 08:37AM	Yes, You Can Time the Market. Find out How - August 26, 2019 Zacks +5.04%
Aug-05-19 08:42AM	Simple Market Timing Strategies That Work - August 05, 2019 Zacks -7.04%
Jul-29-19 06:48PM	Champions Oncology Inc (CSBR) Files 10-K for the Fiscal Year Ended on April 30, 2019 GuruFocus.com
Jul-26-19 06:58AM	Champions Oncology, Inc. (NASDAQ:CSBR) Delivered A Weaker ROE Than Its Industry Simply Wall St.
Jul-15-19 04:35PM	Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019 ACCESSWIRE +12.94%
Jul-12-19 10:00AM	Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 15, 2019 ACCESSWIRE
Jul-02-19 09:35AM	Calculating The Intrinsic Value Of Champions Oncology, Inc. (NASDAQ:CSBR) Simply Wall St.
May-31-19 09:37AM	How Many Champions Oncology, Inc. (NASDAQ:CSBR) Shares Have Insiders Sold, In The Last Year? Simply Wall St.
May-30-19 08:30AM	Champions Oncology Partners with TransCure bioServices to Expand European Business and Operations ACCESSWIRE

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Morris Ronnie	CEO	Mar 17	Buy	4.04	12,382	49,969	858,878	Mar 21 12:30 PM
ACKERMAN JOEL	Director	Oct 19	Option Exercise	3.21	16,667	53,501	1,460,595	Oct 20 01:26 PM
TOBIN SCOTT R	Director	Oct 12	Option Exercise	3.21	10,000	32,100	30,000	Oct 13 09:00 AM
SIDRANSKY DAVID	Director	Oct 12	Option Exercise	3.21	8,333	26,749	770,605	Oct 14 02:27 PM
Breitfeld Philip P.	Director	Oct 12	Option Exercise	3.21	8,333	26,749	18,200	Oct 14 02:25 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience